178 related articles for article (PubMed ID: 35241838)
1. Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells.
North K; Benbarche S; Liu B; Pangallo J; Chen S; Stahl M; Bewersdorf JP; Stanley RF; Erickson C; Cho H; Pineda JMB; Thomas JD; Polaski JT; Belleville AE; Gabel AM; Udy DB; Humbert O; Kiem HP; Abdel-Wahab O; Bradley RK
Nat Biotechnol; 2022 Jul; 40(7):1103-1113. PubMed ID: 35241838
[TBL] [Abstract][Full Text] [Related]
2. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
3. Differential ganciclovir-mediated cell killing by glutamine 125 mutants of herpes simplex virus type 1 thymidine kinase.
Drake RR; Wilbert TN; Hinds TA; Gilbert KM
J Biol Chem; 1999 Dec; 274(52):37186-92. PubMed ID: 10601281
[TBL] [Abstract][Full Text] [Related]
4. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
[TBL] [Abstract][Full Text] [Related]
5. A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs.
Likar Y; Dobrenkov K; Olszewska M; Vider E; Shenker L; Cai S; Pillarsetty N; Hricak H; Ponomarev V
J Nucl Med; 2008 May; 49(5):713-20. PubMed ID: 18413388
[TBL] [Abstract][Full Text] [Related]
6. Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology.
Sun Y; Piñón Hofbauer J; Harada M; Wöss K; Koller U; Morio H; Stierschneider A; Kitamura K; Hashimoto M; Chiba K; Akita H; Anzai N; Reichelt J; Bauer JW; Guttmann-Gruber C; Furihata T
Cancer Lett; 2018 Oct; 433():107-116. PubMed ID: 29960051
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas.
Azatian A; Yu H; Dai W; Schneiders FI; Botelho NK; Lord RV
J Gastrointest Surg; 2009 Jun; 13(6):1044-51. PubMed ID: 19277794
[TBL] [Abstract][Full Text] [Related]
8. Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase.
Haberkorn U; Khazaie K; Morr I; Altmann A; Müller M; van Kaick G
Nucl Med Biol; 1998 May; 25(4):367-73. PubMed ID: 9639298
[TBL] [Abstract][Full Text] [Related]
9. Mutation of herpesvirus thymidine kinase to generate ganciclovir-specific kinases for use in cancer gene therapies.
Mercer KE; Ahn CE; Coke A; Compadre CM; Drake RR
Protein Eng; 2002 Nov; 15(11):903-11. PubMed ID: 12538910
[TBL] [Abstract][Full Text] [Related]
10. Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity.
Kokoris MS; Black ME
Protein Sci; 2002 Sep; 11(9):2267-72. PubMed ID: 12192082
[TBL] [Abstract][Full Text] [Related]
11. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of tumor killing using a combination of tumor immunization and HSV-tk suicide gene therapy.
Ramesh R; Munshi A; Marrogi AJ; Freeman SM
Int J Cancer; 1999 Jan; 80(3):380-6. PubMed ID: 9935178
[TBL] [Abstract][Full Text] [Related]
13. Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine Kinase.
Furukawa J; Inoue K; Ohta K; Yasujima T; Mimura Y; Yuasa H
J Pharmacol Exp Ther; 2017 Jan; 360(1):59-68. PubMed ID: 27807008
[TBL] [Abstract][Full Text] [Related]
14. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
[TBL] [Abstract][Full Text] [Related]
16. Polyamine biosynthesis inhibition enhances HSV-1 thymidine kinase/ganciclovir-mediated cytotoxicity in tumor cells.
Pasanen T; Karppinen A; Alhonen L; Jänne J; Wahlfors J
Int J Cancer; 2003 Apr; 104(3):380-8. PubMed ID: 12569563
[TBL] [Abstract][Full Text] [Related]
17. Non-Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia-enhanced Herpes Simplex Virus Thymidine Kinase Gene Therapy.
Ji J; Weng Q; Zhang F; Xiong F; Jin Y; Hui J; Song J; Gao J; Chen M; Li Q; Shin D; Yang X
Radiology; 2018 Aug; 288(2):612-620. PubMed ID: 29893649
[TBL] [Abstract][Full Text] [Related]
18. Dioscin augments HSV-tk-mediated suicide gene therapy for melanoma by promoting connexin-based intercellular communication.
Xiao J; Zhang G; Li B; Wu Y; Liu X; Tan Y; Du B
Oncotarget; 2017 Jan; 8(1):798-807. PubMed ID: 27903977
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of ganciclovir toxicity in the herpes simplex virus thymidine kinase/ganciclovir administration system by ponicidin.
Hayashi K; Hayashi T; Sun HD; Takeda Y
Cancer Gene Ther; 2000 Jan; 7(1):45-52. PubMed ID: 10678355
[TBL] [Abstract][Full Text] [Related]
20. [Screening of drugs that selectively inhibit uveal melanoma cells with SF3B1 mutations].
Luo X; Ren C; Liu X; Zhang G; Huang S; Yu L; Li Y
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1835-1842. PubMed ID: 35012916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
